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Professor Rona MacKie is a world-renowned British dermatologist,
best known for her extensive research on melanoma. This article will
explore her main contributions to and advancements in the ﬁeld.
Personal Life
RonaMcLeodMacKie was born in 1940 in Dundee, Scotland, an only
child. Her father, Norman Davidson, was a biochemistry professor at
Glasgow University, and so she was familiar with academic life. She
went to four schools before the age of 10 due to familymoves, including
Aberdeen and London, but ﬁnished her education at the Laurel Bank
School for Girls in Glasgow (a private school; University of Glasgow,
n.d.b.). The all-female environment, she thinks, encouraged and
supported her to pursue her interest in maths and physics. In 1994,
she married James Black, a famous Scottish pharmacologist and
recipient of the Nobel Prize for medicine, awarded for his work on
beta-blockers (leading to the development of propranolol) and for his
work on histamine antagonists (developing cimetidine; Sir James
Black, OM, 2010).
Professor MacKie’s hobbies include spending time with her family,
sport, and music. In particular, she gains huge pleasure from spending
time with her ﬁve grandchildren, often taking them skiing and being
“tail-end Charlie.” She is also a keen golfer and hiker. Operatic music is
another interest; she completed an external university degree in opera
studies 10 years ago and supports a large number of opera companies
in the United Kingdom while also serving on the board of the Scottish
Opera for the past 6 years.
Professional Life
She studied at Glasgow University, holding the Oliphant Bursary in
Medicine and graduating in 1963. The scholarship allowedher to pursue
jobs that interestedher rather than rely solely for income and supported
her during her training. She then went on to earn her MD with
commendation in 1970 and became a member of the Royal College of
Physicians in 1971. She worked as a consultant dermatologist for the☆ The authors declare there are no conﬂicts of interest.
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).Greater Glasgow Health Board (1972 to 1978) and also served as an
Honorary Clinical Lecturer at the University of Glasgow. In 1978, she
was awarded a Professorship, making her the ﬁrst British female
dermatologist to become a professor, and also the ﬁrst female professor
ever appointed at Glasgow University in any subject. While she is
now retired from clinical practice, she remains active in research as a
Senior Research Fellow in Glasgow’s Faculty of Medicine (University of
Glasgow, n.d.b.).
In 1983, she was awarded a lifelong fellowship of the Royal Society
of Edinburgh (an organization aimed at stimulating and supporting re-
search excellence across a wide range of disciplines, and also providing
independent, authoritative advice on matters of national interest to
Scotland; Royal Society of Edinburgh, 2015) in recognition of her re-
search excellence, and became International Convener of this organiza-
tion in 2002, responsible for all matters relating to the international
activities of the society.
She served as editor of the British Journal of Dermatology from 1985
to 1988, helping the journal to commemorate its centenary in 1988
(MacKie, 1988) and correctly foreseeing the rise of computerized liter-
ature searches as well as signiﬁcant changes in the handling and distri-
bution of information. She also anticipated increasing subspecialization
among dermatologists in the future, and urged vigilance for broader
journals to remain relevant in the face of competition from subspecialist
dermatology journals (Mackie, 1988).
She was appointed President of the British Association of Dermatol-
ogists for 1994 to 1995 (British Association of Dermatologists, n.d.a.),
and President of the Scottish Dermatological Society for 1997 to 2000
(Scottish Dermatological Society, 2015).
In 1998, she helped to establish the Academy ofMedical Sciences, an
independent body responsible for promoting the diverse spectrum of
medical science within the United Kingdom, and accordingly became
a Founding Fellow of this organization (Academy of Medical Sciences,
n.d.). Also in 1998, she was awarded the Sir Archibald Gray Medal by
the British Association of Dermatologists for outstanding services to
dermatology, one of only 28 dermatologists to receive this award
to date (British Association of Dermatologists, n.d.b.). In 1999, she
was further appointed Commander of the Most Excellent Order of
the British Empire for services to melanoma research (University of
Glasgow, n.d.a.).
She continues to serve on the scientiﬁc advisory board of the
Melanoma International Foundation, an organization established to
ensure that scientiﬁcally sound guidance is freely available to medicalmatologic Society. This is an open access article under the CC BY-NC-ND license
188 History of Dermatologyprofessionals and patients across the world (Melanoma International
Foundation, n.d.).
Research Interests
While Professor MacKie has published on myriad topics—ranging
from a comprehensive undergraduate textbook on clinical dermatology
(MacKie, 1997), to textbooks speciﬁcally focusing upon pediatric der-
matology and dermatopathology (MacKie, 1982), to self-help books
for patients with eczema (MacKie, 1983a), to a guide to inﬂammatory
skin conditions for pharmacists (Whatley and MacKie, 1991)—her
major interest focuses upon melanoma.
Commencing in 1971, she has thus far published 185 articles on the
topic. Aspects of her research helped to answer important clinical
questions that are today considered established fact by the worldwide
dermatology community.
Diagnosis and triage
Professor MacKie was one of the ﬁrst to stimulate interest in
dermoscopy, publishing on the usefulness of the desktop microscope
as an aid to the diagnosis of pigmented lesions (MacKie, 1971).
She challenged contemporary practice in the follow-up of postoper-
ative melanoma patients in the early 1980s, and advocated that they
should undergo complete skin examination rather than a quick inspec-
tion of the excision site and palpation of the draining lymph node basin
(Mackie, 1990). She also challenged the contemporary view that
melanocytic naevi on the palms, soles, and genitalia are most likely to
undergo malignant change (MacKie, 1990).
Calling upon her own earlier work on risk-factors for melanoma,
she developed and subsequently reﬁned a seven-point checklist to
assist family doctors and patients in the timely recognition of early
invasive malignant melanomas, which is still in widespread usage
today (MacKie, 1990; MacKie and Doherty, 1991). She advocated that
a checklist with high sensitivity was important, even at the price of
some speciﬁcity.
Etiology
Working with the Scottish Melanoma Group, MacKie performed
multiple case-control studies that demonstrated that intermittent in-
tense sun exposure inducing sunburn, rather than continuous linear ex-
posure, is a risk factor in the development of malignant melanoma
(MacKie, 1983b; MacKie and Aitchison, 1982).
As remarkable as itmay sound to themodern dermatologist, ﬂuores-
cent lighting had been suggested in some studies in the early 1980s as a
possible risk factor for melanoma (Swerdlow et al., 1988). However, ad-
ditional case-control studies by MacKie and others thankfully showed
this to be highly unlikely, although they did suggest that ultraviolet
sunbeds could be a signiﬁcant risk factor (Swerdlow et al., 1988).
She also worked on a further case-control study showing that the
risk of melanoma is strongly related to overall numbers of benign
melanocytic naevi, and advocated that such people should be warned
about recognizing early melanoma and risk factor avoidance, especially
exposure to ultraviolet radiation (Swerdlow et al., 1986). Subsequently,
using conditional logistic regression, she identiﬁed the four strongest
risk factors for developing cutaneousmelanoma as total numbers of be-
nign naevi, freckling tendency, numbers of clinically atypical naevi, and
history of severe sunburn at any time in life. Using this, she developed a
personal risk factor chart, for use both by medical professionals and by
the general public, to facilitate preventative advice and surveillance of
those at greatest risk (MacKie et al., 1980).
By extension, she showed that childrenwho had undergone chemo-
therapy for hematological malignancies often developed excessivenumbers of melanocytic naevi, and that it would therefore be prudent
for them to undergo regular skin examination (Baird et al., 1992).
She was also involved inmolecular work, showing, for instance, that
N-Rasmutations are not speciﬁcally associated withmelanomas arising
on continuously sun-exposed skin (Carr and MacKie, 1994).
Prognosis
As part of her work with the Scottish Melanoma Group, she was
involved in the long-term surveillance of patients diagnosed with mel-
anoma in Scotland in the 1970s and 1980s. Using sophisticated analyses,
she was able to determine that the most important prognostic factors
were tumor thickness, ulceration, and gender (Mackie et al., 1995).
She also showed that there was no evidence to support so-called check-
point or transition thicknesses (Keefe andMacKie, 1991). Another inter-
esting aspect of this work showed that while the incidence of cutaneous
melanoma is greater among the more afﬂuent, their prognosis is better
than for the less afﬂuent, and this could only partly be explained by
earlier diagnosis and treatment (MacKie and Hole, 1996).
In the mid-1980s, she noted that a greater proportion of British pa-
tients tended to present later compared to other developed countries,
with thick, poor-prognosis lesions, owing to delayed presentation, and
that this probably accounted for the poorer survival in the United
Kingdom compared to elsewhere (Doherty and MacKie, 1986).
Public health
In June 1985, she played a pivotal role in establishing a public health
campaign in Scotland that aimed to both update general practitioners
and enhance awareness among the general public. It resulted in a signif-
icantly greater proportion of thinner, better prognosis tumors being re-
ferred, ultimately leading to a documented reduction in mortality
(MacKie and Doherty, 1988; MacKie and Hole, 1992).
She also publicized the possible health effects of further ozone
depletion among the dermatology community, alongside the head of
the British Antarctic Survey, and was a strong advocate for reducing
the production of chloroﬂuorocarbons (MacKie and Rycroft, 1988).
Treatments
MacKie was involved in multiple trials focusing upon treatment for
metastatic melanoma, including isolated limb perfusion (Scott et al.,
1992), and in evaluating the role of elective regional lymph node dissec-
tion in patientswith cutaneousmelanomawithout any clinical evidence
of metastatic spread (Cascinelli et al., 1998).
Mentoring
Professor MacKie has mentored a large number of dermatologists
and scientists, both men and women, throughout her career. She has
supported women in training during their periods of maternity leave,
helping with the planning required for both the individual and the
service employing them. Personally, she feels her most successful
mentoring has been with her daughter, who is now a senior consultant
in palliative care in theWest of Scotland Oncology Centre. Her daughter
works incredible hours in a highly charged atmosphere while still ﬁnd-
ing time for her three sons and her gorgeous garden.
Conclusion
ProfessorMacKie deserves recognition as one of the foremostﬁgures
in melanoma epidemiology, diagnosis, and prognostication from the
early 1980s to 2000s. Much of what is considered factual with regard
to melanoma by today’s dermatologist was ﬁrst established by her.
189History of DermatologyThanks to her efforts directed towards early recognition and treat-
ment, improved survival rates have been categorically demonstrated.
She has also made substantial contributions to the ﬁelds of under-
graduate dermatological education, and to direct patient education
and self-help.Acknowledgments
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